Closure of USFDA inspection at Zydus' API Unit at Dabhasa, Gujarat

The USFDA conducted a surveillance inspection at the group's API Unit, located at Dabhasa in Gujarat. The inspection was conducted from April 21st to 25th, 2025.

The inspection concluded with 6 observations and none of them were related to Data Integrity. The company is confident to address the observations expeditiously.

Shares of Zydus Lifesciences Limited was last trading in BSE at Rs. 859.10 as compared to the previous close of Rs. 879.85. The total number of shares traded during the day was 24021 in over 1696 trades.

The stock hit an intraday high of Rs. 881.50 and intraday low of 857.90. The net turnover during the day was Rs. 20789096.00.

Source : Equity Bulls

Keywords

ZydusLifesciences INE010B01027 Pharmaceuticals USFDA Inspection APIUnit Dabhasa Gujarat